Saving Lives and Livelihoods is a partnership with the Africa CDC that will enable the purchase of COVID-19 vaccines for at least 65 million people and support the delivery to millions more across the continent. It will also lay the groundwork for vaccine manufacturing in Africa through a focus on human capital development, and strengthen the Africa CDC.
The partnership builds on the ongoing efforts of AVAT, COVAX, WHO, and governments to provide access to vaccines to Africa and support the African Union’s goal of vaccinating 70 percent of Africa’s population by the end of 2022.
The initiative will acquire safe and efficacious vaccines for more than 65 million people, to help close the gap in vaccine availability on the continent.
The Africa CDC will consult Member States’ Ministries of Health and other relevant institutions. The initiative will identify and address needs for the successful distribution of COVID-19 vaccines.
Expanding Vaccine Manufacturing in Africa
The global pandemic has highlighted the importance of enabling Africa to produce critical pharmaceutical products – including vaccines – for its own health security. Enabling the continental manufacturing of vaccines will require a skilled workforce to drive, in the mid-term, critical areas such as process design, quality assurance (including the setup of quality management systems to achieve Good Manufacturing Practices (GMP), and laboratory testing. In the longer-term, this will be complemented by the skills necessary to drive R&D on the continent. The initiative will invest in developing the human capital to enable vaccine manufacturing on the continent.
Strengthening the Africa CDC
The Africa CDC is a technical institution formed by the AU in 2016 to support public health needs of the continent. This initiative will help to ensure the Africa CDC has the capacity and resources to oversee a historic, regional vaccination exercise, to prepare for future health crises, and to lead public health improvements across the continent.